MARKET

HSTO

HSTO

Histogen Inc
NASDAQ
1.350
-0.070
-4.93%
After Hours: 1.420 +0.07 +5.19% 17:43 09/30 EDT
OPEN
1.400
PREV CLOSE
1.420
HIGH
1.470
LOW
1.310
VOLUME
60.29K
TURNOVER
0
52 WEEK HIGH
15.60
52 WEEK LOW
1.300
MARKET CAP
3.37M
P/E (TTM)
-0.2634
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers
Benzinga · 2d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Benzinga · 08/31 18:02
Histogenics Files For U.S. Patent Titled 'NEOCARTILAGE CONSTRUCTS USING UNIVERSAL CELLS'
https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220220265900%22.PGNR.&OS=DN/20220265900
Benzinga · 08/25 16:33
GameStop, Caesars Entertainment, AMC Entertainment among premarket losers' pack
AMC Entertainment Holdings (AMC) -35% ahead of <a href="https://se...
Seekingalpha · 08/22 12:58
12 Health Care Stocks Moving In Friday's Intraday Session
 
Benzinga · 08/19 18:27
Histogen Granted European Patent Titled 'EXTRACELLULAR MATRIX COMPOSITIONS'
https://register.epo.org/application?number=EP09706122
Benzinga · 08/19 14:51
Kohl's, Array Technologies, Bed Bath & Beyond among premarket losers' pack
Blue Water Vaccines (BWV) -30%. Eargo (<a href="https://seekingalpha.co...
Seekingalpha · 08/18 12:25
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Benzinga · 08/18 12:11
More
About HSTO
Histogen Inc. is a clinical-stage therapeutics company. The Company is focused on developing its hypoxia-generated growth factor technology platform and stem cell-free biologic products as restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. The Company's product pipelines include CCM Cosmetics, HST 003, HST 004, and Emricasan. In addition, within its small molecule pipeline, its product candidates also include CTS-2090 and CTS-2096. Its HST-003 is a human extracellular matrix (hECM), which is focused on regenerating hyaline cartilage for the treatment of articular cartilage defects in the knee, with a malleable scaffold that stimulates the body’s own stem cells. HST 004 is a cell conditioned medium (CCM) solution, which is used for treatment of spinal disc repair. Emricasan is an orally active pan-caspase inhibitor being developed for the treatment of COVID-19.

Webull offers kinds of Histogen Inc stock information, including NASDAQ:HSTO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HSTO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HSTO stock methods without spending real money on the virtual paper trading platform.